Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
984.00    -20.50 (-2.04%)
Bid:
979.80
Ask:
980.80
Spread: 1.00 (0.102%)
Market Cap: £4.81b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Transaction in Own Shares

10 Dec 2025 07:00

RNS Number : 9020K
Babcock International Group PLC
10 December 2025
 

Babcock International Group PLC - Transaction in Own Shares

 

10 December 2025

 

Transaction in Own Shares

 

Babcock International Group PLC (the Company) announces today it has purchased the following number of its ordinary shares of 60 pence each through Jefferies International Limited.

Date of purchase:

09 December 2025

Aggregate number of ordinary shares purchased:

15

Highest price paid per share (£ per share):

11.9600

Lowest price paid per share (£ per share):

11.9300

Volume weighted average price paid per share (£):

11.9533

The Company intends to hold the purchased shares in treasury.

Since 24 July 2025, the Company has purchased 7,560,806 shares at a cost of £83,755,739.55.

Following the above transaction, the Company holds 5,757,846 of its ordinary shares in treasury and has 499,838,751 ordinary shares in issue (excluding treasury shares).

The table below contains detailed information about the purchases referred to above.

Schedule of purchases

 

Shares purchased:

Babcock International Group PLC (ISIN: GB0009697037)

Date of purchases:

09 December 2025

Investment firm:

Jefferies International Limited

Aggregate information

 

Venue

Aggregated number of ordinary shares purchased

Volume-weighted average price per share (£)

Lowest price per share (£)

Highest priceper share (£)

London Stock Exchange

15

11.9533

11.9300

11.9600

CBOE CXE

0

0.0000

0.0000

0.0000

CBOE BXE

0

0.0000

0.0000

0.0000

Turquoise

0

0.0000

0.0000

0.0000

Aquis

0

0.0000

0.0000

0.0000

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by Jefferies International Limited on behalf of the Company is set out below.

Transaction Time

Time Zone

Volume

Price

Currency

Platform Code

Transaction reference number

 

15:43:10

GMT

10

11.960

GBP

XLON

00503658682TRLO1.1.1

15:43:10

GMT

1

11.960

GBP

XLON

00503658683TRLO1.1.1

15:51:40

GMT

1

11.950

GBP

XLON

00503663283TRLO1.1.1

15:54:31

GMT

1

11.930

GBP

XLON

00503664741TRLO1.1.1

15:54:31

GMT

2

11.930

GBP

XLON

00503664740TRLO1.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFDFSLAIIE
Date   Source Headline
15th Jan 20217:00 amRNSTrading update
8th Jan 20213:23 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBabcock appoints new Marine CEO
2nd Dec 20204:24 pmRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSHalf-year results
10th Nov 20207:00 amRNSDirector appointment
28th Oct 20207:00 amRNSAppointment of Chief Corporate Affairs Officer
15th Oct 20209:38 amRNSHolding(s) in Company
13th Oct 20209:00 amRNSChief Innovation & Technology Officer Appointment
9th Oct 20209:00 amRNSType 31 briefing
6th Oct 202011:21 amRNSHolding(s) in Company
30th Sep 202012:47 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSBabcock appoints new Chief Financial Officer
21st Sep 20202:56 pmRNSDirector/PDMR Shareholding
15th Sep 202010:20 amRNSDirector/PDMR Shareholding
9th Sep 20208:00 amRNSPublication of Base Prospectus
25th Aug 20209:25 amRNSHolding(s) in Company
18th Aug 20209:44 amRNSHolding(s) in Company
17th Aug 20209:11 amRNSDirector/PDMR Shareholding
14th Aug 20203:40 pmRNSDirector/PDMR Shareholding
14th Aug 20203:39 pmRNSDirector/PDMR Shareholding
4th Aug 20201:39 pmRNSDirector/PDMR Shareholding
4th Aug 202011:33 amRNSResult of AGM
4th Aug 202011:01 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSDirectorate Change
16th Jul 20209:07 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
7th Jul 202011:04 amRNSHolding(s) in Company
7th Jul 202011:02 amRNSHolding(s) in Company
1st Jul 20204:50 pmRNSNotice of AGM
1st Jul 202010:26 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSBabcock appoints new Chief Executive
11th Jun 20203:52 pmRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSFinal Results
19th May 20207:00 amRNSItalian Anti-Trust Authority decision
11th May 20207:00 amRNSRevised date for full year results and AGM
20th Apr 20207:00 amRNSDirector appointment
6th Apr 20207:00 amRNSUpdate on Coronavirus (COVID-19)
19th Mar 20202:47 pmRNSDirector/PDMR Shareholding
6th Mar 20209:43 amRNSSale of Context
14th Feb 202011:23 amRNSHolding(s) in Company
12th Feb 202010:33 amRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSTrading Update
5th Feb 20207:00 amRNSDirectorate Changes
20th Jan 20201:52 pmRNSDirector/PDMR Shareholding
16th Jan 20209:13 amRNSDirector Declaration
25th Nov 201912:41 pmRNSContract for Australian Future Submarine programme
20th Nov 201910:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.